检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵益华[1] 蒋旭敏[1] 黄伟[1] 陈浩[1] 卢毅[1]
机构地区:[1]温州医科大学附属乐清医院泌尿外科,浙江温州325600
出 处:《温州医学院学报》2014年第12期913-916,共4页Journal of Wenzhou Medical College
基 金:温州市卫生局科研基金资助项目(2014B53)
摘 要:目的:探讨应用B超引导"改良一步法"建立标准通道在经皮肾镜碎石术中应用的安全性和可行性。方法:2013年4月至2014年10月我科应用B超引导"改良一步法"建立标准通道进行经皮肾镜碎石术患者共131例,对其通道建立过程及临床结果进行回顾性分析。结果:131例患者通过"改良一步法"均成功建立通道,共建立皮肾通道149个,一期单通道122侧,一期双通道8侧,一期三通道2侧,一期四通道1侧,二期新建通道1侧,平均单个通道建立时间为(6.36±1.04)min。通道建立过程中,扩张过深5例,致上尿路穿孔3例和对侧肾实质损伤2例。无术中术后严重出血、邻近脏器损伤发生。结论:超声引导下"改良一步法"建立标准皮肾通道技术具有安全、可行、简便的优点,值得临床推广应用。Objective: To investigate the safety and efficacy of establishing standard percutaneous renal channel using ultrasound-guided "improved one-step method". Methods: A total of 131 patients with urinary calculi underwent percutaneous nephroscope lithotripsy using ultrasound-guided "improved one-step method" to establish standard percutaneous renal channel in our department from April 2013 to July 2014. The operation process and results of 131 cases were now retrospectively analyzed. Results: Channel in one hundred and thirty-one patients through the "improved one-step" was success fully established, I period of single-channel was establisbed in 122 cases, dual-channel in 8 cases, three-channel in 3 cases and II stage of new channel in 1 case, the time for setting up a single channel was 6 minutes on average. In the process of establishing channel, expanded too deep in 5 cases, including the upper urinary tract perforation in 3 cases and contralateral renal parenchyma injury in 2 cases. None of the patients suffered from severe loss of blood or destruction of adjacent organs during intraoperative or postoperative. Conclusion: As a technology of establishing standard percutaneous renal channel, it is safe and convenient and effective, which is worth of clinical promotion.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145